Repurposing Riluzole for Cancer-Related Cognitive Impairment: a Pilot Trial

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a phase 2a, randomized, double-blinded, placebo-controlled pilot clinical trial determining the impact of riluzole therapy on circulating brain derived neuropathic factor (BDNF) levels of breast cancer survivors with cancer related cognitive impairment.
Epistemonikos ID: 3ff3934f08c25b8fbd2b6f8b58786d172889dc35
First added on: Sep 01, 2024